Huber H - Search Results

1

Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinoma.

Hejna M, Kornek GV, Raderer M, Marosi L, Schneeweiss B, Greul R, Weinländer G, Valencak J, Huber H, Scheithauer W. Hejna M, et al. Among authors: huber h. Oncology. 1998 Nov-Dec;55(6):538-42. doi: 10.1159/000011909. Oncology. 1998. PMID: 9778620 Clinical Trial.

2

Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer.

Scheithauer W, Kornek GV, Raderer M, Schüll B, Schmid K, Längle F, Huber H. Scheithauer W, et al. Among authors: huber h. Ann Oncol. 2002 Oct;13(10):1583-9. doi: 10.1093/annonc/dkf281. Ann Oncol. 2002. PMID: 12377646 Free article. Clinical Trial.

3

The impact of hemoglobin levels on fatigue and quality of life in cancer patients.

Holzner B, Kemmler G, Greil R, Kopp M, Zeimet A, Raderer M, Hejna M, Zöchbauer S, Krajnik G, Huber H, Fleischhacker WW, Sperner-Unterweger B. Holzner B, et al. Among authors: huber h. Ann Oncol. 2002 Jun;13(6):965-73. doi: 10.1093/annonc/mdf122. Ann Oncol. 2002. PMID: 12123343 Free article.

4

Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC).

Pirker R, Krajnik G, Zöchbauer S, Malayeri R, Kneussl M, Huber H. Pirker R, et al. Among authors: huber h. Ann Oncol. 1995 Oct;6(8):833-5. doi: 10.1093/oxfordjournals.annonc.a059324. Ann Oncol. 1995. PMID: 8589023 Free article. Clinical Trial.

5

Treatment of small cell lung cancer patients.

Zöchbauer-Müller S, Pirker R, Huber H. Zöchbauer-Müller S, et al. Among authors: huber h. Ann Oncol. 1999;10 Suppl 6:83-91. doi: 10.1023/a:1008333713858. Ann Oncol. 1999. PMID: 10676558 Review.

6

Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer.

Krajnik G, Mohn-Staudner A, Thaler J, Greil R, Schmeikal S, Marhold F, Deutsch J, Preiss P, Malayeri R, Schäfer-Prokop C, Wein W, Huber H, Pirker R. Krajnik G, et al. Among authors: huber h. Ann Oncol. 2000 Aug;11(8):993-8. doi: 10.1023/a:1008370704612. Ann Oncol. 2000. PMID: 11038036 Free article. Clinical Trial.

7

Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy.

Prior C, Oroszy S, Oberaigner W, Ambrosch G, Mohn-Staudner A, Pfeifer W, Pirker R, Huber H. Prior C, et al. Among authors: huber h. J Cancer Res Clin Oncol. 1999;125(1):42-6. doi: 10.1007/s004320050240. J Cancer Res Clin Oncol. 1999. PMID: 10037276 Clinical Trial.

8

Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial.

Krajnik G, Wein W, Greil R, Marhold F, Mohn-Staudner A, Kummer F, Malayeri R, Zöchbauer-Müller S, Huber H, Pirker R. Krajnik G, et al. Among authors: huber h. Eur J Cancer. 1998 Nov;34(12):1977-80. doi: 10.1016/s0959-8049(98)00235-4. Eur J Cancer. 1998. PMID: 10023326 Clinical Trial.

9

Adjuvant and induction chemotherapy in non-small cell lung cancer.

Pirker R, Malayeri R, Huber H. Pirker R, et al. Among authors: huber h. Ann Oncol. 1999;10 Suppl 6:71-6. Ann Oncol. 1999. PMID: 10676556 Review.

10

Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature.

Fazeny B, Baur M, Prohaska M, Hudec M, Kremnitzer M, Meryn S, Huber H, Grunt T, Tuchmann A, Dittrich C. Fazeny B, et al. Among authors: huber h. J Cancer Res Clin Oncol. 1997;123(1):45-52. doi: 10.1007/BF01212614. J Cancer Res Clin Oncol. 1997. PMID: 8996540 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,104 results

Search Page